Intellectual Property Law
This article was originally published in SRA
Russian president signs new law to strengthen IP protection
You may also be interested in...
Our infographic offers a composite sketch from a decade of US FDA data on refuse-to-file letters.
After the US government invested almost half a billion dollars to ensure Cue Health could scale up production, the FDA announced the self-administered test will now be available over the counter.
The blockbuster drug is expected to see overall sales declines in the next few years, and biosimilar competition could come as soon as 2023.